BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 2, 2009
View Archived Issues
Tetraphase presents novel, potent tetracycline and pentacycline analogues at ICAAC meeting
Read More
International Medica Foundation starts phase II clinical trial for rotavirus vaccine
Read More
Dynavax initiates phase III trial of hepatitis B vaccine Heplisav in chronic kidney disease
Read More
NIH awards Novelos Therapeutics and MGH grant to study NOV-002 and NOV-205
Read More
Icagen initiates proof-of-mechanism study in U.K. of ICA-105665 in pain
Read More
BioCryst initiates phase II study of PNP inhibitor BCX-4208 for treatment of gout
Read More
Eisai and DNDi sign collaboration and license agreement for E-1224 for Chagas disease
Read More
Acrux reports results from phase III trial of Axiron in testosterone deficiency
Read More
Alimera reports 18-month safety and efficacy results from phase II PK study of Iluvien in DME
Read More
Motesanib evaluated in combination therapy in advanced solid tumors
Read More
Novel glycopetide antibacterial agent LT-00029 shows potent in vitro and in vivo activity
Read More
Novacta presents preclinical data on its novel lantibiotic NVB-302 in C. difficile infection
Read More
Novel skeletal protein and muscle modulators disclosed by Cytokinetics
Read More
Roche submits filing to EMEA to extend indication of RoActemra in rheumatoid arthritis
Read More
Roche initiates dosing in phase Ib study of ITMN-191 in chronic HCV genotype-1
Read More
Resverlogix reports results from phase Ib/IIa clinical trial of RVX-208
Read More
Marshall Edwards reports results from in vivo studies of NV-128 in animal xenograft models
Read More
Bayer and Onyx report results from phase II trial of Nexavar and paclitaxel in breast cancer
Read More
LifeCycle reports results from a 12-month extension segment of the phase II LCP-Tacro study
Read More
Antimicrobial MUT-056399 enters phase I study, preclinical activity described
Read More
Orexigen Therapeutics reports results from phase IIb trial of Empatic for obesity
Read More
Experiments detail activity of EGFR, erbB2 and erbB3 signalling inhibitor AZD-8931
Read More
Fovea to be acquired by sanofi-aventis
Read More
rHuPH20 accelerates insulin absorption in patients with type 1 diabetes
Read More
Roche describes alpha1A-adrenoceptor partial agonists for urinary incontinence
Read More
Janssen identifies FAAH inhibitors for the treatment of pain and other conditions
Read More